Provided by Tiger Trade Technology Pte. Ltd.

GH Research PLC

29.01
+0.09000.31%
Post-market: 29.010.00000.00%16:10 EDT
Volume:145.07K
Turnover:4.19M
Market Cap:1.99B
PE:-29.43
High:29.14
Open:28.92
Low:28.38
Close:28.92
52wk High:31.44
52wk Low:11.83
Shares:68.56M
Float Shares:32.37M
Volume Ratio:0.77
T/O Rate:0.45%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9857
EPS(LYR):-0.7900
ROE:-18.79%
ROA:-13.02%
PB:5.53
PE(LYR):-36.72

Loading ...

Is GH Research’s Rising Loss Per Share Reframing the GHRS Cash Burn Narrative?

Simply Wall St.
·
Aug 10

RBC Capital Remains a Buy on GH Research (GHRS)

TIPRANKS
·
Aug 08

Israel's Entera Bio Q2 Net Loss Widens

Reuters
·
Aug 08

Analysts Have Conflicting Sentiments on These Healthcare Companies: InMode (INMD), GH Research (GHRS) and Scholar Rock Holding (SRRK)

TIPRANKS
·
Aug 08

Canada's Xenon Pharma Q2 Net Loss Widens on Higher Expenses

Reuters
·
Aug 07

Praxis Precision Q2 Net Loss Widens on Higher Expenses

Reuters
·
Aug 06

Ireland's GH Research Q2 Net Loss Widens on Higher R&D Costs

Reuters
·
Aug 06

GH Research Plc Q2 EPS USD -0.23

THOMSON REUTERS
·
Aug 06

GH Research Says H1 Loss Widens as R&D Spending Rises on GH001 Clinical, Technical Development Work

Reuters
·
Aug 06

GH Research Publishes Corporate Presentation on Ultra-Rapid, Durable Remission Data for TRD Treatment GH001

Reuters
·
Aug 06

GH Research Q2 FY26 Net Loss Widens to $15.1 Million

Reuters
·
Aug 06

Samsara Stock And 2 Founder Led Software Picks With Real Revenue Growth

Simply Wall St.
·
Jul 19

On Holding Stock And 2 Founder Led Picks Investors Are Watching Closely

Simply Wall St.
·
Jul 17

GH Research Shareholders Re-elect Directors at Annual General Meeting

Reuters
·
Jun 26

What GH Research (GHRS)'s Phase 2a Postpartum Depression Breakthrough Means For Shareholders

Simply Wall St.
·
Jun 18

Do GH Research’s (GHRS) Phase 2a Postpartum Data Subtly Reframe Its Broader Depression Strategy?

Simply Wall St.
·
Jun 10

GH Research announces publication of Phase 2a results for mebufotenin

TIPRANKS
·
Jun 04

GH Research says Phase 2a trial shows inhaled GH001 drives rapid remission in postpartum depression patients

Reuters
·
Jun 04

GH Research says Phase 2b trial shows GH001 cuts anhedonia scores in TRD

Reuters
·
May 21

Stock Track | GH Research PLC Soars 5.19% in Pre-market on Positive Phase 2b Data and New Financing Tools

Stock Track
·
May 18